Impact of Bridge™ Device to Treat Opioid Withdrawal Symptoms

Inclusion Criteria:

• Participant able to provide written informed consent

• Participant is 18 to 65-years old

• Participant has confirmed opioid use disorder (OUD) as defined by the Diagnostic andStatistical Manual of Mental Disorders-5

• Participants is entering an OUD treatment program

Exclusion Criteria:

• Participant requires tapering from another substance at entry to treatment

• Participant is pregnant or lactating

• Participant has a history of hemophilia or psoriasis vulgaris

• Participant has a cardiac pacemaker implant device

• Participant has irritated or broken skin at the site of intended device placement

• Participant is currently participating in, or was enrolled in another clinical trialwithin the last 30 days

• Participant has a history of poor wound healing

• Participant has a severe autoimmune disease or uncontrolled diabetes

• Participant has an open wound/abscess infection/MRSA

• Participant has a history of a chronic pain in the last 90 days

• Participant has a serious medical condition which in the judgment of the principalinvestigator or his/her designee would make study participation unsafe, or wouldmake intervention compliance difficult

• Participant has a psychiatric illness (bipolar disorder, schizophrenia, or otherpsychotic disorder, active suicidal ideation with a plan within the last month orsuicide attempt)